9-70550347-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001366145.2(TRPM3):c.3575-673A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.488 in 152,084 control chromosomes in the GnomAD database, including 18,659 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.49 ( 18659 hom., cov: 33)
Consequence
TRPM3
NM_001366145.2 intron
NM_001366145.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.400
Publications
2 publications found
Genes affected
TRPM3 (HGNC:17992): (transient receptor potential cation channel subfamily M member 3) The product of this gene belongs to the family of transient receptor potential (TRP) channels. TRP channels are cation-selective channels important for cellular calcium signaling and homeostasis. The protein encoded by this gene mediates calcium entry, and this entry is potentiated by calcium store depletion. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.8 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TRPM3 | NM_001366145.2 | c.3575-673A>G | intron_variant | Intron 24 of 25 | ENST00000677713.2 | NP_001353074.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TRPM3 | ENST00000677713.2 | c.3575-673A>G | intron_variant | Intron 24 of 25 | NM_001366145.2 | ENSP00000503830.2 |
Frequencies
GnomAD3 genomes AF: 0.488 AC: 74125AN: 151966Hom.: 18656 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
74125
AN:
151966
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.488 AC: 74153AN: 152084Hom.: 18659 Cov.: 33 AF XY: 0.490 AC XY: 36416AN XY: 74336 show subpopulations
GnomAD4 genome
AF:
AC:
74153
AN:
152084
Hom.:
Cov.:
33
AF XY:
AC XY:
36416
AN XY:
74336
show subpopulations
African (AFR)
AF:
AC:
16824
AN:
41486
American (AMR)
AF:
AC:
7538
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
1814
AN:
3472
East Asian (EAS)
AF:
AC:
4240
AN:
5168
South Asian (SAS)
AF:
AC:
1647
AN:
4824
European-Finnish (FIN)
AF:
AC:
6402
AN:
10568
Middle Eastern (MID)
AF:
AC:
144
AN:
294
European-Non Finnish (NFE)
AF:
AC:
34073
AN:
67980
Other (OTH)
AF:
AC:
1036
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1912
3824
5735
7647
9559
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
652
1304
1956
2608
3260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1823
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.